Endocrinology, Diabetes and Metabolism

  • A Potential Dramatic Change in Treating Type 1 Diabetes
    9/6/23

    Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

  • Dandona Honored For Study of Hypogonadism and its Treatment With Testosterone
    7/31/23

    Paresh Dandona, MD, PhD, has been honored with a Lifetime Achievement Award from the Androgen Society for recognition of his continuing and progressive contributions to the study of hypogonadotropic hypogonadism and its treatment with testosterone, which led to several novel discoveries.

  • Reanalysis of IRIS Study Data Shows Benefits of Lower Doses
    4/1/22

    Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine in the Division of Endocrinology, Diabetes and Metabolism, is co-author on a study that shows low doses of pioglitazone used to treat diabetes in patients with insulin resistance may be preferable. In this study, patients had a history of previous stroke or transient ischemic attack (TIA). 

  • Studying Effect of Bariatric Surgery in Obese Male Teens
    3/8/22

    A study led by senior author Paresh Dandona, MD, PhD, shows that bariatric surgery not only treats obesity and reverses Type 2 diabetes, it also reverses low testosterone levels in severely obese male teens.

  • Record 163 Posters Presented at Celebration of Scholarship
    9/20/21

    Four medical residents, three medical students and one postdoctoral associate earned honors for outstanding poster presentations at the Office of Graduate Medical Education’s third annual Celebration of Scholarship.

  • Faculty, Students, Residents Share Artistry at Talent Show
    5/6/21

    Jacobs School of Medicine and Biomedical Sciences faculty, students and residents showcased their artistic talents in the school’s first virtual talent show April 28.